Achiel Van Peer

2.1k total citations
43 papers, 1.2k citations indexed

About

Achiel Van Peer is a scholar working on Pharmacology, Anesthesiology and Pain Medicine and Molecular Biology. According to data from OpenAlex, Achiel Van Peer has authored 43 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pharmacology, 10 papers in Anesthesiology and Pain Medicine and 8 papers in Molecular Biology. Recurrent topics in Achiel Van Peer's work include Anesthesia and Sedative Agents (10 papers), Drug Solubulity and Delivery Systems (7 papers) and Antibiotics Pharmacokinetics and Efficacy (7 papers). Achiel Van Peer is often cited by papers focused on Anesthesia and Sedative Agents (10 papers), Drug Solubulity and Delivery Systems (7 papers) and Antibiotics Pharmacokinetics and Efficacy (7 papers). Achiel Van Peer collaborates with scholars based in Belgium, United States and Sweden. Achiel Van Peer's co-authors include Robert Woestenborghs, J. Heykants, R. De Coster, Zbigniew Żylicz, Claire Mackie, Donald Heald, Nancy Van Osselaer, Frédéric Camu, Steven L. Shafer and Donald R. Stanski and has published in prestigious journals such as Anesthesiology, Pharmaceutical Research and Journal of Pharmaceutical Sciences.

In The Last Decade

Achiel Van Peer

43 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Achiel Van Peer Belgium 19 319 235 215 208 202 43 1.2k
Edward J. Randinitis United States 18 232 0.7× 246 1.0× 194 0.9× 231 1.1× 371 1.8× 43 1.3k
Kyoung Soo Lim South Korea 22 352 1.1× 150 0.6× 237 1.1× 255 1.2× 237 1.2× 84 1.5k
Tomonori Tateishi Japan 23 545 1.7× 114 0.5× 188 0.9× 244 1.2× 292 1.4× 80 1.5k
Koujirou Yamamoto Japan 22 493 1.5× 83 0.4× 179 0.8× 267 1.3× 165 0.8× 102 1.4k
William F. Ebling United States 25 252 0.8× 97 0.4× 186 0.9× 217 1.0× 101 0.5× 47 1.4k
Robert A. Ronfeld United States 18 260 0.8× 89 0.4× 236 1.1× 147 0.7× 148 0.7× 29 1.0k
Julie Ducharme Canada 20 341 1.1× 75 0.3× 221 1.0× 323 1.6× 153 0.8× 45 1.3k
Bart A. Ploeger Netherlands 26 498 1.6× 115 0.5× 230 1.1× 630 3.0× 274 1.4× 67 2.3k
Michael Skinner United States 16 187 0.6× 207 0.9× 412 1.9× 280 1.3× 70 0.3× 25 1.4k
Ziad Hussein United Kingdom 26 201 0.6× 491 2.1× 172 0.8× 229 1.1× 554 2.7× 99 1.9k

Countries citing papers authored by Achiel Van Peer

Since Specialization
Citations

This map shows the geographic impact of Achiel Van Peer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Achiel Van Peer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Achiel Van Peer more than expected).

Fields of papers citing papers by Achiel Van Peer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Achiel Van Peer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Achiel Van Peer. The network helps show where Achiel Van Peer may publish in the future.

Co-authorship network of co-authors of Achiel Van Peer

This figure shows the co-authorship network connecting the top 25 collaborators of Achiel Van Peer. A scholar is included among the top collaborators of Achiel Van Peer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Achiel Van Peer. Achiel Van Peer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Flanagan, Talia, Achiel Van Peer, & Anders Lindahl. (2016). Use of physiologically relevant biopharmaceutics tools within the pharmaceutical industry and in regulatory sciences: Where are we now and what are the gaps?. European Journal of Pharmaceutical Sciences. 91. 84–90. 24 indexed citations
2.
T’jollyn, Huybrecht, Jan Snoeys, Jan Van Bocxlaer, et al.. (2016). Strategies for Determining Correct Cytochrome P450 Contributions in Hepatic Clearance Predictions: In Vitro–In Vivo Extrapolation as Modelling Approach and Tramadol as Proof-of Concept Compound. European Journal of Drug Metabolism and Pharmacokinetics. 42(3). 537–543. 5 indexed citations
3.
Vandenbossche, Joris, et al.. (2016). Single‐Dose Pharmacokinetic Study of Tramadol Extended‐Release Tablets in Children and Adolescents. Clinical Pharmacology in Drug Development. 5(5). 343–353. 2 indexed citations
4.
T’jollyn, Huybrecht, Jan Snoeys, An Vermeulen, et al.. (2015). Physiologically Based Pharmacokinetic Predictions of Tramadol Exposure Throughout Pediatric Life: an Analysis of the Different Clearance Contributors with Emphasis on CYP2D6 Maturation. The AAPS Journal. 17(6). 1376–1387. 34 indexed citations
5.
Loryan, Irena, Vikash Sinha, Claire Mackie, et al.. (2014). Mechanistic Understanding of Brain Drug Disposition to Optimize the Selection of Potential Neurotherapeutics in Drug Discovery. Pharmaceutical Research. 31(8). 2203–2219. 52 indexed citations
6.
Sinha, Vikash K., Stefan S. De Buck, Luca A. Fenu, et al.. (2011). Towards a Better Prediction of Peak Concentration, Volume of Distribution and Half-Life after Oral Drug Administration in Man, Using Allometry. Clinical Pharmacokinetics. 50(5). 307–318. 15 indexed citations
7.
Thygesen, Peter, Panos Macheras, & Achiel Van Peer. (2009). Physiologically-Based PK/PD Modelling of Therapeutic Macromolecules. Pharmaceutical Research. 26(12). 2543–2550. 25 indexed citations
8.
Peer, Achiel Van. (2009). Variability and Impact on Design of Bioequivalence Studies. Basic & Clinical Pharmacology & Toxicology. 106(3). 146–153. 34 indexed citations
9.
Karalis, Vangelis, Panos Macheras, Achiel Van Peer, & Vinod P. Shah. (2008). Bioavailability and Bioequivalence: Focus on Physiological Factors and Variability. Pharmaceutical Research. 25(8). 1956–1962. 45 indexed citations
10.
Sinha, Vikash K., Stefan S. De Buck, Luca A. Fenu, et al.. (2008). Predicting Oral Clearance in Humans. Clinical Pharmacokinetics. 47(1). 35–45. 37 indexed citations
11.
Aarons, Leon, Mats O. Karlsson, Anthony Man, et al.. (2004). Modelling and Simulation in the Development and use of Anti-Cancer Agents: An Underused Tool?. Journal of Pharmacokinetics and Pharmacodynamics. 31(6). 419–440. 13 indexed citations
12.
Piotrovsky, Vladimir, Achiel Van Peer, Nancy Van Osselaer, Martin Armstrong, & Jeroen Aerssens. (2003). Galantamine Population Pharmacokinetics in Patients with Alzheimer's Disease: Modeling and Simulations. The Journal of Clinical Pharmacology. 43(5). 514–523. 27 indexed citations
13.
Zhao, Qinying, et al.. (2002). Galantamine Pharmacokinetics, Safety, and Tolerability Profiles Are Similar in Healthy Caucasian and Japanese Subjects. The Journal of Clinical Pharmacology. 42(9). 1002–1010. 9 indexed citations
14.
Piotrovsky, Vladimir, et al.. (1998). Effects of demographic variables on vorozole pharmacokinetics in healthy volunteers and in breast cancer patients. Cancer Chemotherapy and Pharmacology. 42(3). 221–228. 8 indexed citations
15.
Gupta, Suneel, et al.. (1998). Fentanyl Delivery from an Electrotransport System: Delivery is a Function of Total Current, Not Duration of Current. The Journal of Clinical Pharmacology. 38(10). 951–958. 46 indexed citations
16.
Lefebvre, Romain A., Achiel Van Peer, & Robert Woestenborghs. (1997). Influence of itraconazole on the pharmacokinetics and electrocardiographic effects of astemizole. British Journal of Clinical Pharmacology. 43(3). 319–322. 27 indexed citations
17.
Keyser, Jacques De, Vera Van de Velde, Ronald L. L. A. Schellens, et al.. (1997). Safety and pharmacokinetics of the neuroprotective drug lubeluzole in patients with ischemic stroke. Clinical Therapeutics. 19(6). 1340–1351. 8 indexed citations
18.
Gepts, E., Steven L. Shafer, Frédéric Camu, et al.. (1995). Linearity of Pharmacokinetics and Model Estimation of Sufentanil. Anesthesiology. 83(6). 1194–1204. 131 indexed citations
19.
Peer, Achiel Van, et al.. (1993). Pharmacokinetics of the novel antipsychotic agent risperidone and the prolactin response in healthy subjects. Clinical Pharmacology & Therapeutics. 54(3). 257–268. 267 indexed citations
20.
Zazgórnik, J, F Kokot, Sonja Koch, et al.. (1991). Pharmacokinetics of Ritanserin in Patients Undergoing Hemodialysis. The Journal of Clinical Pharmacology. 31(7). 657–661. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Edward J. Randinitis Breakdown of academic impact, for papers by Kyoung Soo Lim Breakdown of academic impact, for papers by Tomonori Tateishi Breakdown of academic impact, for papers by Koujirou Yamamoto Breakdown of academic impact, for papers by William F. Ebling Breakdown of academic impact, for papers by Robert A. Ronfeld Breakdown of academic impact, for papers by Julie Ducharme Breakdown of academic impact, for papers by Bart A. Ploeger Breakdown of academic impact, for papers by Michael Skinner Breakdown of academic impact, for papers by Ziad Hussein
Rankless by CCL
2026